Double Crown Glory, FlowRay Photon Skin-Rejuvenation Device Reshapes the Home Skincare Era with Disruptive Technology
Shanghai, China, April 17, 2025 -- Recently, the world's first FlowRay Photon Skin-Rejuvenation Device, co-developed by the Massachusetts Institute of Technology (MIT), Shanghai Jiao Tong University, and Fudan University School of Medicine, has made its groundbreaking debut. Combining 'medical-grade precision' with 'consumer-friendly convenience,' this revolutionary product claimed two prestigious international awards—the US Muse Design Gold Award and the French Design Gold Award—within its first month of launch, solidifying its status as a phenomenal innovation in 2025's beauty tech landscape. Integrating three core technologies and five transformative effects, this device is redefining at-home skincare as the 'technical pinnacle' of home beauty devices, ushering in a new era of accessible precision phototherapy.
The Muse Design Gold Award and French Design Gold Award highlight its innovations in technology and user experience, respectively. The Muse jury praised its 'seamless fusion of aerospace-grade materials and ergonomic design,' while the French Design Award lauded its golden curvature tailored to Asian facial contours, transforming clinical-grade hardware into a fashion-forward tech masterpiece. This 'invisible medical-grade' design philosophy marks the first time professional skincare technology has entered households in the elegant form of consumer electronics.
Unveiling the 3+5 Technology
Now available globally, this trailblazing device has pioneered the concept of "luxury medical skincare at home." As Dr. Emma Wilson, Chief Scientist at MIT Media Lab, stated: "This is not just a triumph of technical specifications, but a milestone in bringing cutting-edge medical technology from labs into daily life." When the sapphire dome illuminates, a new era of precision skincare for all begins.
Contact Info:
Name: HarryHou
Email: Send Email
Organization: Onwind Technology (Shanghai) Co., Ltd
Website: https://www.flowray.com.cn/
Release ID: 89157922
Should you come across any errors, concerns, or inconsistencies within this press release's content, we urge you to reach out without delay by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will promptly address your feedback within 8 hours and take appropriate measures to resolve any identified issues or guide you through the removal process. Providing accurate and dependable information remains our utmost priority.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
39 minutes ago
- Boston Globe
Ozempic, the internet, GPS: Here are 5 things New England researchers helped develop with federal funding
Here are some of the most impactful, federally-funded scientific breakthroughs that have come out of New England. Advertisement Weight loss drugs Often referred to by the well-known brand names In the 1980s, Joel Habener and Svetlana Mojsov, both at Massachusetts General Hospital at the time, were among the first to Advertisement 'When they were discovering these things, I'm sure they didn't realize that if we fast forwarded 45 to 50 years, these would be the most talked about [medications],' said Dr. Fatima Cody Stanford, obesity specialist and associate professor of medicine and pediatrics at Harvard Medical School. The US Food and Drug Administration 'What happened here in the '70s and '80s is translating into what we're seeing in 2025,' Stanford said. 'They were developed within the academic setting with The internet Researchers at the Massachusetts Institute of Technology played a significant role in the creation of the internet through a project called John Guttag, a professor of computer science and electrical engineering at MIT, emphasized that while the internet itself was not invented in a single place, 'MIT's fingerprints were all over it.' 'A lot of it was also done by MIT graduates in other places,' he said. 'There were a lot of things that didn't happen at MIT but were clearly influenced by people from MIT.' ARPAnet, which stands for Advanced Research Projects Agency Network, was the direct precursor to and is the basis of today's internet, said Guttag. A computer scientist affiliated with MIT and later Harvard, J.C.R. Licklider, was key in the internet's development. In 1960, he authored a paper outlining his vision of using computer networks for communication, laying the groundwork for ARPAnet, which was first used in 1969. Advertisement 'The Defense Department, immensely wisely, picked a few targets and funded them to do something pretty dramatic over a long period of time,' Guttag said. Pacemakers and defibrillators Defibrillators, medical devices that deliver an electric shock to the heart to restore a normal heart rhythm, are near universally found in malls, offices, and schools these days, saving countless lives. Between 1950 and 1960, Dr. Paul Zoll, a cardiologist at Beth Israel Hospital and professor at Harvard Medical School, Cohen said the development of the external defibrillator was a 'pioneering' discovery 'to help humanity.' 'That's the whole purpose of medical investigation, medical research — it's always ongoing and improving," Cohen said. Black hole imaging In New England, a researcher built one of the algorithms to piece together the first image of a black hole. That image was The Advertisement In 2022, a team led by scientists at the These images are helping scientists discover crucial details about astrophysics, including the ability to test theories about how gas behaves around black holes. 'Black holes are natural laboratories where we can test Einstein's theory of gravity in ways we can't anywhere else in the cosmos,' said Doelman. 'We can see black holes for the first time in ways we would have not thought possible even a decade ago.' Navigation systems During World War II, MIT researchers helped develop the first widely-used electronic navigation system, known as 'It was a very important moment in both MIT's history and the history of federal funding of science and technology,' said David Mindell, professor of aeronautics and astronautics and the history of engineering and manufacturing at MIT. He said the system played a Many researchers who worked on the project went on to become key to GPS development, Mindell said. 'Federal funding for these ecosystems has been enormously important over a long time period,' he said, adding that GPS alone probably 'generated more economic value' over a 40-year period than the entire budgets of the government agencies that helped launch the navigational system. Advertisement Emily Spatz can be reached at
Yahoo
4 hours ago
- Yahoo
Why has there been a global surge of new Covid variant NB.1.8.1?
India is the latest country to report a surge in new Covid cases, as the latest variant, NB.1.8.1, spreads across the globe. Cases have now been reported in Asian countries such as Thailand, Indonesia and China, while the UK Health Security Agency recorded the first 13 cases in England last week. But the true numbers are unlikely to be known, given the significant decrease in the number of people testing compared to the figures seen during the global pandemic five years ago. NB.1.8.1 stemmed from the Omicron variant and was first detected in January this year. It has quickly spread across China and Hong Kong, and has now been recorded in several states across the United States and Australia. By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 per cent a month before. The WHO declared the NB.1.8.1 strain a 'variant under monitoring' on 23 May, which means scientists believe it could potentially affect the behaviour of the virus. Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spreads more easily than other variants. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation. Dr Chun Tang, GP at UK private healthcare centre Pall Mall Medical, said: 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' 'Its spread has been identified in around 22 countries,' said Dr Naveed Asif, GP at The London General Practice. 'The WHO assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' However, the 'Nimbus' variant, as it has been dubbed, does appear to be more transmissible than previous strains, with notable increases reported in India, Hong Kong, Singapore and Thailand, notes Dr Asif. Common symptoms of Nimbus include a severe sore throat, fatigue, mild cough, fever, muscle aches and congestion. It has also been reported that some patients have experienced gastrointestinal symptoms such as nausea and diarrhoea. Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness.
Yahoo
4 hours ago
- Yahoo
Why has there been a global surge of new Covid variant NB.1.8.1?
India is the latest country to report a surge in new Covid cases, as the latest variant, NB.1.8.1, spreads across the globe. Cases have now been reported in Asian countries such as Thailand, Indonesia and China, while the UK Health Security Agency recorded the first 13 cases in England last week. But the true numbers are unlikely to be known, given the significant decrease in the number of people testing compared to the figures seen during the global pandemic five years ago. NB.1.8.1 stemmed from the Omicron variant and was first detected in January this year. It has quickly spread across China and Hong Kong, and has now been recorded in several states across the United States and Australia. By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 per cent a month before. The WHO declared the NB.1.8.1 strain a 'variant under monitoring' on 23 May, which means scientists believe it could potentially affect the behaviour of the virus. Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spreads more easily than other variants. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation. Dr Chun Tang, GP at UK private healthcare centre Pall Mall Medical, said: 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' 'Its spread has been identified in around 22 countries,' said Dr Naveed Asif, GP at The London General Practice. 'The WHO assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' However, the 'Nimbus' variant, as it has been dubbed, does appear to be more transmissible than previous strains, with notable increases reported in India, Hong Kong, Singapore and Thailand, notes Dr Asif. Common symptoms of Nimbus include a severe sore throat, fatigue, mild cough, fever, muscle aches and congestion. It has also been reported that some patients have experienced gastrointestinal symptoms such as nausea and diarrhoea. Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness.
